"Pfizer shares fell Thursday following a Food and Drug Administration warning about company advertising for two controversial pain drugs.
"The FDA sent a letter to the New York drugmaker stating that television and print ads for the drugs Bextra and Celebrex were misleading. The letter said the ads did not fully disclose side effects while also making 'unsubstantiated effectiveness claims.'" [TheStreet.com]
